StoxAakaar Medical Technologies Limited
NSE: AAKAAR · Unclassified
Ask the data
Instant answers about Aakaar Medical Technologies Limited — computed from its filings, no language modelPrice & valuation
split & bonus adjusted · pick a metric and rangeAnnual performance
annual · ₹ crore · line = operating margin| FY26 | |
|---|---|
| Revenue | 67.0 |
| EBITDA | 10.3 |
| Operating margin | 15.4% |
| Interest | 1.8 |
| Depreciation | 0.1 |
| Profit before tax | 9.2 |
| Tax | 2.5 |
| Net profit | 6.6 |
| EPS ₹ | 4.99 |
| Operating cash flow | -8.4 |
| Capex | 0.6 |
| Dividend paid | 0.0 |
| Total assets | 79.4 |
| Equity | 54.5 |
Half-yearly performance
last 3 half years · ₹ crore| H1 FY26 | H2 FY26 | H1 FY27 | |
|---|---|---|---|
| Revenue | 25.3 | 41.6 | 43.7 |
| Operating profit | -0.2 | 10.4 | 5.4 |
| Operating margin | -0.9% | 25.0% | 12.4% |
| Other income | 0.3 | 0.6 | 0.3 |
| Interest | 1.0 | 0.8 | 0.8 |
| Depreciation | 0.1 | 0.1 | 0.1 |
| Profit before tax | -1.0 | 10.2 | 4.8 |
| Tax | -0.2 | 2.8 | 1.3 |
| Net profit | -0.8 | 7.4 | 3.5 |
| EPS ₹ | -0.63 | 5.24 | 2.50 |
| Revenue YoY | — | — | 72.7% |
Returns & margins
trailing-twelve-month, per half year| H2 FY26 | H1 FY27 | |
|---|---|---|
| ROE | 12.2% | 18.9% |
| ROCE | 15.1% | 21.6% |
| Net margin | 9.9% | 12.8% |
| EBITDA margin | 15.2% | 18.6% |
| Debt / equity | 0.34 | 0.33 |
| Interest coverage | 6.11 | 10.58 |
| Asset turnover | 0.84 | 0.96 |
Balance sheet
equity vs borrowings over time · ₹ crore| SEP '25 | MAR '26 | SEP '26 | |
|---|---|---|---|
| Share capital | 14.2 | 14.2 | 14.2 |
| Other equity / reserves | 33.0 | 40.4 | 43.9 |
| Total equity | 47.1 | 54.5 | 58.1 |
| Borrowings | 17.1 | 18.5 | 18.9 |
| Current liabilities | 23.0 | 23.9 | 29.2 |
| Non-current liabilities | 1.1 | 1.0 | 1.2 |
| Total assets | 71.2 | 79.4 | 88.5 |
| Property, plant & equipment | 0.2 | 0.2 | 0.2 |
| Investments | 0.0 | 0.0 | 0.0 |
| Inventories | 19.1 | 19.8 | 25.9 |
| Receivables | 26.5 | 37.2 | 54.2 |
| Cash & equivalents | 1.4 | 16.2 | 0.1 |
Cash flow
annual · ₹ crore · line = free cash flow| FY26 | |
|---|---|
| Cash from operations | -8.4 |
| Cash from investing | 0.1 |
| Cash from financing | 18.8 |
| Capex | 0.6 |
| Free cash flow | -8.9 |
| Dividends paid | 0.0 |
Where the assets sit
Sep '26 · ₹ crorePeer comparison
largest in Unclassified · this company in bold| Company | Market cap ₹cr | Price | P/E | P/B | ROE |
|---|---|---|---|---|---|
| Avantel Limited | 36,86,04,549 | 138.69 | — | 1059360.68 | 0.0% |
| Ducol Organics And Colours Limited | 19,55,275 | 120.00 | — | 20089.13 | 0.0% |
| Jio Platforms Limited | 12,57,181 | 1,406.40 | — | 3.57 | — |
| SBI Funds Management Limited | 1,01,750 | 499.55 | — | — | — |
| Tamilnadu Telecommunication Limited | 91,314 | 9.93 | — | — | — |
| Manipal Health Enterprises Limited | 76,294 | 646.70 | — | — | — |
| INDO-MIM Limited | 59,042 | 1,219.50 | — | — | — |
| AvenuesAI Limited | 45,138 | 129.25 | 153.6 | 9.51 | 6.2% |
| Dhoot Transmission Limited | 32,761 | 1,601.60 | — | 8.11 | — |
| 3M India Limited | 31,071 | 27,570.00 | 53.8 | 17.57 | 32.7% |
| Aakaar Medical Technologies Limited | 103 | 72.50 | 9.4 | 1.77 | 18.9% |
StoxGud checklist: Bullish setup · 9/10
- Price above 50-day average
- Price above 200-day average
- 50-day average above 200-day (uptrend)
- RSI in healthy 40–70 zone
- Positive 1-year return
- Return on equity above 15%
- Debt to equity below 1
- Revenue growing year on year
- Net profit margin above 10%
- P/E below industry median
A rules-based screen of trend, momentum, quality and valuation. Educational only — not a buy or sell recommendation.
Returns & technicals
FAQs
What is the share price of Aakaar Medical Technologies Limited?
Aakaar Medical Technologies Limited (AAKAAR) closed at ₹72.50 on NSE on 06 Nov 2026.
What is the market cap of Aakaar Medical Technologies Limited?
₹103 crore at the latest close.
What is the P/E ratio of Aakaar Medical Technologies Limited?
9.4, on trailing-twelve-month earnings from its filings.
How fast is Aakaar Medical Technologies Limited growing?
Aakaar Medical Technologies Limited: Latest-half-year revenue is up 72.7% year on year.
How profitable is Aakaar Medical Technologies Limited?
On a trailing-twelve-month basis return on equity is 18.9%, return on capital employed 21.6%, operating margin 18.6%, net margin 12.8%.
How much debt does Aakaar Medical Technologies Limited have?
Aakaar Medical Technologies Limited is lightly geared: debt to equity is 0.33 with borrowings of ₹19 cr against cash of ₹0 cr (balance sheet of 2026-09-30). Operating profit covers interest 10.6 times.
Financials parsed from Aakaar Medical Technologies Limited's own XBRL filings to NSE (standalone), ₹ crore unless marked. Half-yearly from H1 FY26, annual from FY26, balance sheet from Sep '25. * = derived (full year minus the other half). This company is on NSE's SME platform and reports results half-yearly. Information only, not investment advice.